BRPI0705630F8 - Processo de produção de vacina gênica lipossomal, vacina gênica lipossomal e uso da mesma - Google Patents

Processo de produção de vacina gênica lipossomal, vacina gênica lipossomal e uso da mesma

Info

Publication number
BRPI0705630F8
BRPI0705630F8 BRC10705630A BRPI0705630A BRPI0705630F8 BR PI0705630 F8 BRPI0705630 F8 BR PI0705630F8 BR C10705630 A BRC10705630 A BR C10705630A BR PI0705630 A BRPI0705630 A BR PI0705630A BR PI0705630 F8 BRPI0705630 F8 BR PI0705630F8
Authority
BR
Brazil
Prior art keywords
gene vaccine
liposomal gene
liposomal
administration
production process
Prior art date
Application number
BRC10705630A
Other languages
English (en)
Portuguese (pt)
Inventor
A M Coelho Castelo Arlete
Lopes Silva Célio
Gaziola De La Torre Lucimara
Helena Andrade Santana Maria
Silva Rosada Rogério
Original Assignee
Univ Estadual Campinas Unicamp
Univ Sao Paulo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Estadual Campinas Unicamp, Univ Sao Paulo filed Critical Univ Estadual Campinas Unicamp
Priority to BRC10705630A priority Critical patent/BRPI0705630F8/pt
Priority to PCT/BR2008/000387 priority patent/WO2009073941A2/en
Publication of BRPI0705630A2 publication Critical patent/BRPI0705630A2/pt
Publication of BRPI0705630E2 publication Critical patent/BRPI0705630E2/pt
Publication of BRPI0705630B1 publication Critical patent/BRPI0705630B1/pt
Publication of BRPI0705630F1 publication Critical patent/BRPI0705630F1/pt
Publication of BRPI0705630B8 publication Critical patent/BRPI0705630B8/pt
Publication of BRPI0705630F8 publication Critical patent/BRPI0705630F8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BRC10705630A 2007-12-12 2007-12-12 Processo de produção de vacina gênica lipossomal, vacina gênica lipossomal e uso da mesma BRPI0705630F8 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRC10705630A BRPI0705630F8 (pt) 2007-12-12 2007-12-12 Processo de produção de vacina gênica lipossomal, vacina gênica lipossomal e uso da mesma
PCT/BR2008/000387 WO2009073941A2 (en) 2007-12-12 2008-12-12 Ternary liposomal composition containing a polynucleotide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRC10705630A BRPI0705630F8 (pt) 2007-12-12 2007-12-12 Processo de produção de vacina gênica lipossomal, vacina gênica lipossomal e uso da mesma

Publications (6)

Publication Number Publication Date
BRPI0705630A2 BRPI0705630A2 (pt) 2010-12-28
BRPI0705630E2 BRPI0705630E2 (pt) 2011-03-09
BRPI0705630B1 BRPI0705630B1 (pt) 2020-09-24
BRPI0705630F1 BRPI0705630F1 (enExample) 2021-03-30
BRPI0705630B8 BRPI0705630B8 (pt) 2021-05-25
BRPI0705630F8 true BRPI0705630F8 (pt) 2022-01-18

Family

ID=40755920

Family Applications (1)

Application Number Title Priority Date Filing Date
BRC10705630A BRPI0705630F8 (pt) 2007-12-12 2007-12-12 Processo de produção de vacina gênica lipossomal, vacina gênica lipossomal e uso da mesma

Country Status (2)

Country Link
BR (1) BRPI0705630F8 (enExample)
WO (1) WO2009073941A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2661253T3 (pl) * 2011-01-04 2017-08-31 Archivel Farma, Sl Preparat liposomowy odpowiedni do leczenia lub zapobiegania gruźlicy
TW202228727A (zh) * 2020-10-01 2022-08-01 德商拜恩迪克公司 適用於治療之微脂體ｒｎａ調配物之製備及儲存

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384923B2 (en) * 1999-05-14 2008-06-10 Lipoxen Technologies Limited Liposomes
US6110745A (en) * 1997-07-24 2000-08-29 Inex Pharmaceuticals Corp. Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions

Also Published As

Publication number Publication date
BRPI0705630F1 (enExample) 2021-03-30
BRPI0705630B1 (pt) 2020-09-24
WO2009073941A2 (en) 2009-06-18
BRPI0705630B8 (pt) 2021-05-25
BRPI0705630A2 (pt) 2010-12-28
WO2009073941A3 (en) 2009-08-27
BRPI0705630E2 (pt) 2011-03-09

Similar Documents

Publication Publication Date Title
BR112015006623A2 (pt) laquinimod e pridopidina para o tratamento de doenças neurodegenerativas
BRPI1011220A2 (pt) composição farmacêutica, métodos para tratar uma doença ou distúrbio, para administração respiratória de dois ou mais agentes ativos, para administração respiratória de uma combinação de agentes ativos, e, para preparar uma composição adequada.
UA104320C2 (ru) Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии
PH12015500407B1 (en) Methods of treating hypertriglyceridemia
BR112013022789A2 (pt) composições farmacêuticas que compreendem metformina e um inibidor dpp-4 ou um inibidor sglt-2
BR112015007814A2 (pt) diagnóstico, prevenção e tratamento de doenças da articulação
MX2010001401A (es) Productos medicos mejorados, revestidos con preparaciones farmaceuticas, la produccion de los mismos y el uso de los mismos.
BR112014031394A2 (pt) composições e métodos para absorção transmucosa
BR112015006093A2 (pt) combinação de rasagilina e pridopidine para o tratamento de desordens neurodegenerativas, particularmente na doença de huntington
BR112015014458A2 (pt) derivados de manose para o tratamento de infecções bacterianas
BR112014031788A2 (pt) composições e métodos para o tratamento de diabetes
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
BR112014011981B8 (pt) Formulações farmacêuticas sólidas orais, seus processos de preparação e usos
PL2081910T3 (pl) Nowe związki
BR112017020039A2 (pt) composição farmacêutica, kit, método, processo para preparar uma composição e solução farmacêutica
CL2008001820A1 (es) Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer.
BR112015006656A8 (pt) composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos
HN2009003424A (es) (oxazolidinon-5-il-metil) -2-tiofen-carboxamidas sustituida y su uso en el campo de la coagulacion sanguinea
BR112012017300A2 (pt) processo de para preparação de uma biomassa compreendendo plantaricina e usos da mesma no campo médico
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
GT201300125A (es) 1h-pirazol-5-olato sódico sustituido
BR112015006363A2 (pt) combinações farmacêuticas compreendendo ligantes angiopoietina-2/dll4 duplos e agentes anti-vegf-r
BRPI0519351A2 (pt) medicamentos para o tratamento ou prevenÇço de doenÇas fibràticas
BRPI0705630F8 (pt) Processo de produção de vacina gênica lipossomal, vacina gênica lipossomal e uso da mesma
BR112014015578A8 (pt) composições farmacêuticas tópicas compreendendo bexaroteno e um corticosteróide

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06V Preliminary requirement: patent application procedure suspended [chapter 6.22 patent gazette]
B06J Correction of requirement [chapter 6.10 patent gazette]

Free format text: O PRESENTE PEDIDO TEVE UMA PARECER DE EXIGENCIA 6.22 NOTIFICADO NA RPI NO 2569 DE 31-03-2020, TENDO SIDO CONSTATADO QUE O MESMO NAO FOI DISPONIBILIZADO, ASSIM REPUBLICO A REFERIDA PUBLICACAO.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/09/2020, OBSERVADAS AS CONDICOES LEGAIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B09A Decision: intention to grant [chapter 9.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/09/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/12/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A 13A ANUIDADE.

B24D Patent annual fee: restoration after fee payment

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/12/2007, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.